Global Medical REIT Inc. Announces Pricing of Public Offering of 8.00% Series B Preferred Stock
Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to receive gross proceeds of approximately $50,000,000, before deducting underwriting discounts and commissions and estimated offering expenses. The Company has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares of Series B Preferred Stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
The Company intends to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisitions and repaying indebtedness, including amounts outstanding under the Company’s credit facility.
The Company intends to apply to list the Series B Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrB."
Raymond James, BMO Capital Markets, Stifel and Baird are serving as the book-running managers for the offering. Janney Montgomery Scott, B. Riley Securities, Ladenburg Thalmann, Berenberg and Colliers Securities LLC are serving as co-managers.
The offering is being made pursuant to the Company’s shelf registration statement, as amended, which was declared effective by the U.S. Securities and Exchange Commission (“SEC”) on April 4, 2024. Copies of the final prospectus supplement and accompanying prospectus relating to this offering, which will be filed with the SEC may be obtained from the SEC’s website at www.sec.gov or by contacting: Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, Florida 33716, by telephone at (800) 248-8863, or by email at prospectus@raymondjames.com; BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036, or by email at bmoprospectus@bmo.com; Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate Department, 1201 Wills Street, Suite 600, Baltimore, MD 21231, or by email at syndprospectus@stifel.com; and Robert W. Baird & Co. Incorporated, Attention: Syndicate Department, 777 E. Wisconsin Avenue, Milwaukee, WI 53202, telephone: 800-792-2473, email: syndicate@rwbaird.com.

